Table 2 Follow-up clinic visits among those who linked to hypertension care after population level screening (N = 2038)
From: Hypertension control in integrated HIV and chronic disease clinics in Uganda in the SEARCH study
|  | HIV+ (n = 89) | HIV-(n = 1949) | Overall (N = 2038) |
|---|---|---|---|
Total number of follow-up visits | 580 | 15,073 | 15,653 |
Median duration of follow-up (days) (IQR) | 583 (84, 1122) | 742 (48, 1198) | 738 (50, 1195) |
Interval in days between scheduled visits [Median (IQR)] | 59 (29, 84) | 56 (29, 84) | 56 (29, 84) |
Interval in days between actual visits [Median (IQR)] | 65 (42, 90) | 63 (35, 91) | 63 (35, 91) |
Interval between scheduled visits | |||
 More frequent than clinical indication | 141 (24%) | 3056 (20%) | 3197 (20%) |
 Less frequent than clinical indication | 216 (37%) | 6013 (39%) | 6229 (39%) |
Late visitsa [%, median (IQR)] | 150 (24%) | 2825 (18%) | 2975 (18%) |
Follow-up visits with controlled blood pressure | 301 (48%) | 7173 (46%) | 7474 (46%) |
Follow-up visits with controlled blood pressure on 2 consecutive visits | 182 (34%) | 4160 (29%) | 4342 (29%) |
Visits with no blood pressure measurement | 33 (3.5%) | 609 (3.5%) | 641 (3.5%) |